연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1257. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Kim HJ, Kim JH, Chie EK, Young PD, Kim IA, Kim IH.
Radiat Oncol. 2012 Mar 20;7:39. Link
1256. Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
Koh Y, Kim I, Shin DY, Bae JY, Kim HK, Yoon SS, Park SS, Lee DS, Park S, Kim BK.
Biol Blood Marrow Transplant. 2012 Jan;18(1):37-43. Link
1255. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
Cho HJ, Shin DY, Kim JH, Bae JY, Lee KH, See CJ, Kim N, Park EK, Ra EK, Lee JE, Hong YC, Kim HK, Park SS, Yoon SS, Lee DS, Han KS, Park MH, Park S, Kim BK, Kim I.
Clin Transplant. 2012 May-Jun;26(3):476-83. Link
1254. RANTES Polymorphisms and the Risk of Graft-versus-Host Disease in Human Leukocyte Antigen-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation.
Shin DY, Kim I, Kim JH, Lee YG, Kang EJ, Cho HJ, Lee KH, Kim HJ, Park EH, Lee JE, Bae JY, See CJ, Yoon SS, Park SS, Han KS, Park MH, Hong YC, Park S, Kim BK.
Acta Haematol. 2012 Nov 30;129(3):137-145. Link
1253. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer.
Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH.
Anticancer Res. 2012 Aug;32(8):3169-75. Link
1252. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
Choi JS, Seo J, Jung EJ, Kim EJ, Lee GK, Kim WH.
Anticancer Res. 2012 Nov;32(11):5031-7. Link
1251. Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer.
Nam KH, Lee BL, Park JH, Kim J, Han N, Lee HE, Kim MA, Lee HS, Kim WH.
Pathobiology. 2013;80(2):87-94. doi: 10.1159/000341685. Epub 2012 Oct 3. Link
1250. Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma.
Jung EJ, Jung EJ, Min SY, Kim MA, Kim WH.
Hum Pathol. 2012 Oct;43(10):1559-66. doi: 10.1016/j.humpath.2011.12.002. Epub 2012 Mar 21. Link
1249. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.
Lee HE, Kim MA, Lee HS, Jung EJ, Yang HK, Lee BL, Bang YJ, Kim WH.
Br J Cancer. 2012 Jul 10;107(2):325-33. doi: 10.1038/bjc.2012.237. Epub 2012 May 29. Link
1248. Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.
Kim J, Min SY, Lee HE, Kim WH.
Int J Cancer. 2012 Feb 15;130(4):817-26. doi: 10.1002/ijc.26038. Epub 2011 May 5. Link